PH indicator device and formulation

Information

  • Patent Grant
  • 10288590
  • Patent Number
    10,288,590
  • Date Filed
    Monday, November 6, 2017
    6 years ago
  • Date Issued
    Tuesday, May 14, 2019
    5 years ago
Abstract
Disclosed herein are devices and methods for determining the pH of fluid. Example devices include a device comprising a surface configured to contact the fluid and a pH indicator covalently bound thereto, wherein the pH indicator has a first color prior to contact with the fluid and changes color as a function of the pH of the fluid.
Description
BACKGROUND

The need to reliably test the pH of a fluid sample is a requirement in a plethora of industries, particularly where the pH is indicative of potential quality, safety or health concerns. pH measurements are important in, for example, medicine, biology, chemistry, agriculture, forestry, food science, environmental science, oceanography, civil engineering, chemical engineering, nutrition, water treatment and water purification.


The pH of water is routinely tested. The pH of drinking water is routinely monitored to ensure that it is safe to drink, whereas the water in swimming pools is routinely tested to ensure that it is safe to swim in. Monitoring alterations in the pH of fish ponds or river water can be indicative of environmental pollution. In agriculture and horticulture, knowledge of the pH of the soil is not only instructive in the selection of suitable crops but also discerns whether there are local environmental issues, such as pollution. In the food and brewing industries, maintaining a proper pH range is essential in many of the physical and chemical reactions that take place during food and drink processing. Monitoring the pH of bodily fluids can be a useful diagnostic. For example, it has been demonstrated that the pH of saliva can predict susceptibility to a range of diseases, including cancer, heart disease and osteoporosis.


pH testing is conventionally performed using pH meters, but these are impractical for a variety of applications as they require regular calibration using standard buffer solutions. Furthermore, the glass electrodes are fragile and must be kept constantly wet, normally in an acidic solution, in order to avoid dehydration of the pH sensing membrane and subsequent dysfunction of the electrode. Disposable pH test strips are available, but due to the permanence of the colour change as a function of pH of the test sample, the strips are unable to demonstrate any changes in pH over time. Additionally, the disposable characteristic adds to the cost implications.


A need exists for a device which enables the real-time, reversible and stable detection of pH in a fluid.


SUMMARY

This application discloses devices and methods related to devices having pH indicators for monitoring the pH of a fluid. Other advantages and improvements will be apparent to one of skill in the art upon review of the application.


In one aspect, a device is provided for determining pH of a fluid sample. The device preferably includes a surface configured to contact the fluid and a pH indicator covalently immobilised thereon, wherein the pH indicator has a first colour prior to contact with the fluid and changes colour along a colour spectrum as a function of the pH of the fluid. In embodiments, the pH indicator changes colour in response to change in pH and this colour change is detectable at, for example, intervals of about a 0.1 unit, about 0.2 unit, about 0.3 unit about 0.4 unit or about 0.5 unit interval of pH. It is envisaged that the detection level will vary based on the type of detection means utilised. For example, an electronic detector such as a colour meter capable of detecting changes in colour of light, has the capability to detect a 0.1 unit change in pH. In comparison, the human eye is only capable of visually detecting a colour change which is associated with about a 0.5 unit change in pH. In embodiments, the pH indicator utilised in the device is able to detect the pH between about pH 0 and about pH 14 and indicates changes in pH by way of a colour change along a colour spectrum, with each colour in the spectrum being associated with a particular pH. In embodiments, the pH indicator is able to detect a pH between about pH 5.0 and about pH 10.0. In embodiments, the pH indicator is able to detect a pH between about pH 5.5 and about pH 9.5. More particularly the pH indicator is able to detect a pH between about pH 6.5 and about pH 9.5. Suitable pH indicators include phenylazo compounds such as those listed in Table 1 which are available from Fraunhofer EMFT, Germany.









TABLE 1







Phenylazo compounds










Code
Chemical name







GJM-514
2-[4(2-hydroxyethylsulfonyl)-




phenyl]diazenyl]-4-methylphenol



GJM-546
1-hydroxy-4-[4[(hydroxyethylsulphonyl)-




phenylazo]-napthalene-2-sulphonate



GJM-492
2-fluoro-4-[4[(2-hydroxyethanesulphonyl)-




phenylazo]-6-methoxy phenol



GJM-534
4-[4-(2-hydroxyethylsulphonyl)-phenylazo]-




2,,6-dimethoxyphenol










In some embodiments, the pH indicator is a triarylmethane dye. In some embodiments, the pH indicator is a fluorescent dye.


In embodiments, the pH indicator comprises a combination of compounds which allows a broader pH range to be detected than can be detected by use of a single compound. For example, the pH indicator comprises a combination of phenylazo compounds. In embodiments, the combination comprises at least two phenylazo compounds selected from the group listed in Table 1. In embodiments the combination comprises at least three phenylazo compounds selected from the group listed in Table 1. In embodiments, the combination comprises at least one phenylazo compound selected from the group listed in Table 1 and at least one compound that is not a phenylazo compound. In embodiments, derivatives or modifications of the phenylazo compounds listed in Table 1 are envisaged.


In embodiments, the device is a cellulosic material, for example a cellulose pad. In embodiments, the device is a non-woven mesh or perforated film.


In some embodiments, the fluid is a liquid. Non-limiting examples includes water. In some embodiments, the fluid is a gas, for example for use in a face mask. In some embodiments, the fluid is a moisture. Non-limiting examples include the moisture associated with a soil sample. In some embodiments, the fluid is a bodily sample. Non-limiting examples include, saliva, urine, blood, sweat/perspiration.


In another aspect, a device is provided for determining pH of a fluid sample. The device preferably includes: (a) a fluid-contacting surface, (b) an opposing non-fluid contacting surface, (c) a pH indication zone comprising a pH indicator covalently immobilised therein which indicates the pH of a fluid, wherein the colour of the pH indicator changes in response to a change in the pH of the fluid, and (d) at least one conduit for directing fluid towards the pH indication zone. The conduit helps direct fluid toward the pH indicator without materially altering the pH en route to the indicator. In certain embodiments, the material of the conduit contains no acid or base functionality, that is to say, it is neutral and can not remove any acid or base entities from the fluid until it reaches the pH indicating system. In certain embodiments, the device has an outer surface and the pH indication zone is located at or near the outer surface. In other embodiments, the device has a peripheral edge extending between the fluid contacting surface and the opposing non-fluid contacting surface and pH indication zone is located at or near to this peripheral edge. In certain embodiments, the conduit directs fluid laterally towards the pH indication zone. In embodiments, the pH indicator changes colour in response to change in pH and this colour change is detectable at, for example, intervals of about a 0.1 unit, about 0.2 unit, about 0.3 unit about 0.4 unit or about 0.5 unit interval of pH. It is envisaged that the detection level will vary based on the type of detection means utilised. For example, an electronic detector such as a colour meter has the capability to detect a 0.1 unit change in pH. In comparison, the human eye is only capable of visually detecting a colour change which is associated with about a 0.5 unit change in pH. In embodiments, the pH indicator utilised in the device is able to detect the pH between pH 0 and 14 and indicates changes in pH by way of a colour change along a colour spectrum, with each colour in the spectrum being associated with a particular pH. In embodiments, the pH indicator is able to detect pH between about pH 5 and about pH10. Particularly, the pH indicator is able to detect pH between about pH 5.5 and about pH 9.5. More particularly, the pH indicator is able to detect pH between about pH 6.5 and about pH 9.5. Suitable pH indicators include phenylazo compounds such as those selected from the group listed in Table 1. In embodiments, the pH indicator comprises a combination of compounds which allows a broader pH range to be detected than can be detected by use of a single compound. For example, the pH indicator comprises a combination of phenylazo compounds. In embodiments, the combination comprises at least two phenylazo compounds selected from the group listed in Table 1. In embodiments, the combination comprises at least three phenylazo compounds selected from the group listed in Table 1. In embodiments, the combination comprises at least one phenylazo compound selected from the group listed in Table 1 and at least one compound that is not a phenylazo compound. In embodiments, derivatives or modifications of the phenylazo compounds listed in Table 1 are envisaged.


In a further aspect, a formulation is provided for indicating pH of a fluid. Advantageously, the pH indicator is covalently immobilised within the formulation and is therefore not washed away by the fluid upon contact. The formulation preferably includes a dye that functions as a pH indicator. The dye may include a phenylazo compound, where the colour of the phenylazo compound changes in response to a change in the pH of the fluid. In embodiments, the pH dye changes colour in response to a 0.5 unit interval change in pH. For example, the pH indicator has a different colour for each 0.5 unit interval change in pH. The pH indicator utilised in the device is able to detect the pH between pH 5 and 10, particularly between pH 5.5 and 9.5 and more particularly between pH 6.5 and 9.5. Suitable pH indicators include phenylazo compounds such as those selected from the group listed in Table 1. In embodiments, the pH indicator comprises a combination of compounds which allows a broader pH range to be detected than can be detected by use of a single compound. For example, the pH indicator comprises a combination of phenylazo compounds. In embodiments, the combination comprises at least two phenylazo compounds selected from the group listed in Table 1. In embodiments, the combination comprises at least three phenylazo compounds selected from the group listed in Table 1. In embodiments, the combination comprises at least one phenylazo compound selected from the group listed in Table 1 and at least one compound that is not a phenylazo compound. In embodiments, derivatives or modifications of the phenylazo compounds listed in Table 1 are envisaged. In embodiments, the formulation is applied to a device for use in detecting pH at the point of manufacture. In embodiments, the formulation is an adhesive. In embodiments, the adhesive is a low tack adhesive, for example a silicon adhesive. In other embodiments, it is envisaged that the formulation is a gel, for example, a conformable semi-rigid or rigid gel, that does not disintegrate upon contact with the fluid to be tested. The formulation can be used in a device according to the first and/or second aspect.


In another aspect, a method is provided for monitoring the pH of a fluid. The method preferably comprises the steps of: (a) providing a device comprising a surface configured to contact the fluid, said surface having a pH indicator covalently bound thereto, wherein the pH indicator has a first colour prior to contact with the fluid and changes colour as a function of the pH of the fluid, (b) contacting the device with the fluid, (c) assessing the colour of the pH indicator. It is envisaged that the method can be utilised in numerous applications in which the knowledge of the pH of a fluid sample is paramount to determining quality control or safety. Non-limiting examples of potential applications include: food storage; packaging spoilage indicators; wine; brewing; analysis of drinking water, swimming pool water, river water or fish ponds; agriculture and horticulture; clothing, for example perspiration analysis; in-line monitoring of processes, gases, liquids; skin care—medical (dermatology) or cosmetic; coatings of containers and surfaces to detect changes/inconsistencies; monitoring drug release or stability.


In a further aspect, a device comprises a fluid contacting surface having a pH indicating means covalently bound thereto, wherein the pH indicating means has a first colour prior to contact with a fluid and changes colour as a function of the pH of the fluid.


In another aspect a device comprises a pH indicating means, wherein the pH indicating means has a first colour prior to contact with a fluid and changes colour as a function of the pH of the fluid and a conduit means for directing the fluid towards the pH indicating means.


Variations and modifications of these embodiments will occur to those of skill in the art after reviewing this disclosure. The foregoing features and aspects may be implemented, in any combination and sub-combinations (including multiple dependent combinations and sub-combinations), with one or more other features described herein. The various features described or illustrated above, including any components thereof, may be combined or integrated in other systems. Moreover, certain features may be omitted or not implemented.


Further areas of applicability of the disclosed devices and methods will become apparent from the detailed description provided hereinafter. It should be understood that the detailed description and specific examples, while indicating particular embodiments, are intended for purposes of illustration only and are not intended to limit the scope of the disclosure or any of the claims that may be pursued.





DESCRIPTION OF THE DRAWINGS

The foregoing and other objects and advantages will be appreciated more fully upon consideration of the following detailed description, taken in conjunction with the accompanying drawings, in which like reference numbers refer to like parts throughout. These depicted embodiments are to be understood as illustrative and not limiting in any way:



FIGS. 1A and 1B are side cross-sectional views of an illustrative device having a pH indicator, the colour of which changes as a result of alterations in the pH of a fluid.



FIGS. 2A and 2B are side cross-sectional views of an illustrative device in which a fluid is guided via a conduit to a pH indication zone which includes a pH indicator, the colour of the indicator changes as an indication of the pH of the fluid.



FIG. 3 is a photograph of a Post-Op sample dyed with GJM-514, illustrating changes in colour of the dye in response to solution changing pH along a pH unit interval scale.



FIGS. 4A-F are graphic representations of colour pen measurements for the Post-Op sample illustrated in FIG. 3.



FIG. 5 is a photograph of a Post-Op sample dyed with a first combination of dyes, illustrating changes in colour of the dye combination in response to a solution changing pH along a pH unit interval scale.



FIGS. 6A-D are graphic representations of colour pen measurements for the Post-Op sample illustrated in FIG. 5.



FIG. 7 is a photograph of a Post-Op sample dyed with a second combination of dyes, illustrating changes in colour of the dye combination in response to a buffered solution changing pH along a pH unit interval scale.



FIGS. 8A-E are graphic representations of the colour pen measurements for the Post-Op sample illustrated in FIG. 7.



FIG. 9 is a photograph of a Post-Op sample dyed with a third combination of dyes, illustrating changes in colour of the dye combination in response to a buffered solution changing pH along a pH unit interval scale.



FIGS. 10A-F are graphic representations of the colour pen measurements for the Post-Op sample illustrated in FIG. 9.



FIG. 11 is a photograph of a Post-Op sample dyed with a fourth combination of dyes, illustrating changes in colour of the dye combination in response to a buffered solution changing pH along a pH unit interval scale.



FIGS. 12A-E are graphic representations of the colour pen measurements for the Post-Op sample illustrated in FIG. 11.



FIGS. 13 A-F are photographs of pH sensitive gauze in ex-vivo wound model with alternating pH 5 and pH 8 horse serum being pumped in.



FIG. 13A is a photograph of pH5 after 2.5 hours approx.



FIG. 13B is a photograph of pH5 after 5.5 hours approx.



FIG. 13C is a photograph of pH 8 after 8 hours approx.



FIG. 13D is a photograph of pH 5 after 3.5 hours approx.



FIG. 13E is a photograph of pH 5 after 5.5 hours approx. with the flow rate of horse serum increased at 3.5 hours.



FIG. 13F is a photograph of pH 5 after 7.5 hours with the flow rate of horse serum increased at 3.5 hours and at 5.5 hours.



FIG. 14A to F are photographs of pH sensitive foam (V.A.C. WhiteFoam trade mark of KCT) in an ex-vivo wound model with alternating pH5 and pH 8 horse serum being pumped in.



FIG. 14A is a photograph at pH 5 after 2.5 hours approx.



FIG. 14B is a photograph at pH 5 after 5.5 hours approx.



FIG. 14C is a photograph at pH 8 after 15 hours approx.



FIG. 14D is a photograph at pH 5 after 3.5 hours approx.



FIG. 14E is a photograph at pH 5 after 5.5 hours approx., with the flow rate of horse scrum increased at 3.5 hours.



FIG. 14F is a photograph at pH 5 after 7.5 hours approx., with the flow rate of horse serum increased at 3.5 hours and at 5.5 hours.



FIG. 15 A to E are photographs of pH sensitive gauze in an ex-vivo wound model with alternating basic and acidic water being pumped in.



FIG. 15A is a photograph at 8 am Day 1 showing basic pH.



FIG. 15B is a photograph at 12:57 pm Day 1 (5 hours) showing basic pH.



FIG. 15C is a photograph at 08:03 am Day 2 (24 hours) showing basic pH.



FIG. 15D is a photograph at 12:41 pm Day 2 (5 hours) showing acidic pH.



FIG. 15E is a photograph at 15:06 Day 2 (7 hours) showing acidic pH.



FIG. 15F is a photograph at 16:47 Day 2 (9 hours) showing acidic pH.



FIG. 16A to F are photographs of pH sensitive foam in an ex-vivo wound model with alternating basic and acidic water being pumped in.



FIG. 16A is a photograph at 8 am Day 1 showing basic pH.



FIG. 16B is a photograph at 12:57 pm Day 1 (5 hours) showing basic pH.



FIG. 16C is a photograph at 08:03 am Day 2 (24 hours) showing basic pH.



FIG. 16D is a photograph at 09:06 Day 2 (1 hour) showing acidic pH.



FIG. 16E is a photograph at 15:06 Day 2 (7 hours) showing acidic pH.



FIG. 16F is a photograph at 16:47 Day 2 (9 hours) showing acidic pH.



FIG. 17A to H are photographs of pH sensitive foam in a clear Perspex wound model with alternating basic and acidic water.



FIG. 17A is a photograph at 8 am Day 1 showing basic pH.



FIG. 17B is a photograph at 12:56 Day 1 (5 hours) showing basic pH.



FIG. 17C is a photograph at 16:20 Day 1 (8.5 hours) showing basic pH.



FIG. 17D is a photograph at 8:02 am Day 2 (24 hours) showing basic pH.



FIG. 17E is a photograph at 09:05 am Day 2 (1 hour) showing acidic pH.



FIG. 17F is a photograph at 10:50 am Day 2 (3 hours) showing acidic pH.



FIG. 17G is a photograph at 13:26 Day 2 (5.5 hours) showing acidic pH.



FIG. 17H is a photograph at 15:05 Day 2 (7 hours) showing acidic pH.





DETAILED DESCRIPTION

To provide an understanding of the devices and methods describe herein, certain illustrative embodiments and examples will now be described.



FIG. 1A depicts a device 100 having a fluid-contacting surface 102 and an opposing non-fluid-contacting surface 104. FIG. 1B depicts the device 100 being brought into contact with a fluid 106. The device 100 can be made of any material that is suitable for contact with the fluid without disintegrating.


The device further includes a pH indicator 108 which is applied to one or both of surfaces 102 and/or 104. The pH indicator is covalently immobilised on or adjacent to the surface 102 and/or 104 so that it is not washed away by the fluid.


In embodiments, the pH indicator is chemically bound to the surface 102 and/or 104. For example, the pH indicator is covalently bound directly to the surface 102 and/or 104. In alternative embodiments, the surface 102 and/or 104 is provided within an adhesive and the pH indicator is covalently bound to reactive moieties within the adhesive. For example, a conventional acrylic adhesive, such as K5 (Smith & Nephew, Inc) used in the construction of wound dressings contains residues of 2-hydroxy-ethylmethacrylate, which provide a reactive functional hydroxyl (OH) group, pendant to the polymer backbone, to which the pH indicator can be covalently bound. Other suitable adhesives include acrylic-based adhesives with pendant OH or COOH groups.


In embodiments on which the pH indicator is only applied to one surface of a non-porous device, then an indication, for indicating which side the pH indicator is applied to may be provided. This indication allows the user to appropriately orient the device during placement on or in the fluid to ensure that the surface which has the pH indicator is correctly orientated and comes into contact with the fluid.


The pH indicator may be applied across substantially the entire surface 102 and/or 104, to allow any variations in the pH at the meniscus of the fluid sample to be identified. Alternatively, the pH indicator may be applied to discrete areas of surfaces 102 and/or 104. The pH indicator exhibits a first colour prior to contact with a fluid and changes colour as a function of the pH of the fluid. The first colour of the pH indicator may be colourless.


The pH indicator is capable of reversibly changing colour in response to pH. In embodiments, the pH indicator is a phenylazo compound. In certain embodiments, the phenylazo compound is selected from the group listed in Table 1. In some embodiments, the phenylazo compound is not 2-[4(2-hydroxyethylsulfonyl)-phenyl]diazenyl]-4-methylphenol. In some embodiments, the phenylazo compound is not hydroxy-4-[4[(hydroxyethylsulphonyl)-phenylazo]-napthalene-2-sulphonate. In some embodiments, the phenylazo compound is not 2-fluoro-4-[4[(2-hydroxyethanesulphonyl)-phenylazo]-6-methoxy phenol. In some embodiments, the phenylazo compound is not 4-[4-(2-hydroxyethylsulphonyl)-phenylazo]-2,6-dimethoxyphenol. In certain embodiments, the phenylazo compound is 2-[4(2-hydroxyethylsulfonyl)-phenyl]diazenyl]-4-methylphenol. In some embodiments, the pH indicator includes a plurality of phenylazo compounds. In some embodiments, the pH indicator includes a combination of phenylazo compounds, for example a combination of phenylazo compounds selected from the group listed in Table 1. In some embodiments, the pH indicator includes a combination of two phenylazo compounds. In some embodiments, the pH indicator includes a combination of three phenylazo compounds. In some embodiments, 2-[4(2-hydroxyethylsulfonyl)-phenyl]diazenyl]-4-methylphenol is combined with at least one other phenylazo compound selected from the group listed in Table 1. The ratio of phenylazo compound may be 1:1, but other ratios are envisaged, for example, but in no way limiting, 0.5:1.5 or 1.5:0.5 or 1:2 or 2:1 or 1:0.1. In alternative embodiments, the pH indicator includes at least one phenylazo compound, for example a phenylazo compound selected from the group listed in Table 1 and at least one other compound that is not a phenylazo compound. In certain embodiments, the pH indicator is not a phenylazo compound.



FIGS. 2 A&B illustrate a device in which temporal changes in pH can be monitored whilst the device is in situ. FIG. 2A shows a side cross-sectional view of a device 200 comprising an absorbent element 204, the lower surface of which is a fluid-contacting surface 206. The device also comprises a pH indication zone 208 which is located at or adjacent to the opposing non fluid-contacting surface 210. This pH indication zone includes a pH indicator (e.g., as disclosed herein) which is capable of reversibly changing colour in response to changes in pH. In this illustrated embodiment, the pH indication zone 208 is disposed above the absorbent layer 204, so the pH indicator can be monitored over time without having to remove the device from any substrate that it is adhered to.


A transparent layer 212 overlays at least part of the pH indication zone, which protects the integrity of the pH indicator but still allows the user to monitor the colour of the pH indicator over time. The device includes at least one conduit that is configured to direct fluid to the pH indication zone 206, ensuring that the pH of the fluid is not materially altered as it passes through the components of the device. One or a plurality of conduits could be used. As shown in FIGS. 2 A&B, two conduits are used, although one or more other conduits could also be included. The two conduits 214 and 216 are oriented vertically and extend across the device. The conduits are preferably sealed, so as to not exchange fluid with the absorbent layer, but are in communication with the pH indication zone 208 and direct the fluid to the pH indication zone 208 located in the upper part of the device. The conduits may be in the form of narrow capillaries which transmit the fluid towards the pH indication zone 208. The conduits may incorporate or may be formed from wicking materials, for example, woven, non-woven, knitted, tows or fibres made of suitable materials to facilitate wicking of the fluid towards the pH indication zone 208. In alternative embodiments, a pH indication zone is provided at or near a lateral edge 218 or 220 of the device and at least one conduit is provided within the device to direct the fluid laterally to the pH indication zone. In some embodiments, the pH indication zone is provided in a layer of the device which forms an outer surface of the device and a transparent cover layer is not used. In some embodiments, the conduits may take the form of a long strip or be of an elongated lozenge shape when viewed from the fluid-contacting surface. Alternatively, the conduit may be formed of crosses or quadrilateral shapes.


Methods of immobilising a phenylazo dye on the devices illustrated in FIGS. 1 and 2 are also contemplated. An example includes the following steps:


In a first step, 25 mg of a phenylazo pH indicating dye, for example a phenylazo pH indicating dye selected from the group listed in Table 1, is reacted with 140 μl concentrated sulphuric acid for 30 mins to form a dye solution.


In a second step, 200 ml of distilled water is added to the dye solution formed in the first step.


In a third step, 406 μl of a 32% w/v solution of sodium hydroxide is added to the solution formed in the second step.


In a fourth step, 25.45 ml of a 2.36M solution of sodium carbonate is added to the solution formed in the third step.


In a fifth step, 1.35 ml of a 32% w/v solution of sodium hydroxide is added to the solution formed in the fourth step and the volume made up to 250 ml with distilled water.


In a sixth step, a material on which the pH indicating dye is to be bound is placed in the solution and left to react for approximately 1-2 hours. Examples of suitable materials include, but are not limited to: TENCEL fibres of the Durafiber product, polyurethane foam of the Allevyn product, cellulose pad of the Opsite Post-op product, or K5 adhesive-coated polyurethane film, all available from Smith & Nephew, Inc. The material is then washed with distilled water until no dye is released. The material is then dried.


EXAMPLES

A sample of the pad from an Opsite Post-Op dressing (Smith & Nephew, Inc) was prepared in different samples, and each sample was covalently bound with one or a combination of phenylazo dyes, selected from GJM-514, GJM-492, GJM-546, and GJM-534. The structures of these dyes are shown in Table 1. It was discovered that these dyes had colour-changing characteristics that varied according to changes in pH. The Post-Op samples were covalently bound with GJM-514 alone or with GJM-514 combined with one of GJM-492, GJM-546 and GJM-534 using the method as described above in relation to FIGS. 1-3. The Post-Op material was exposed to buffered solutions having a pH of 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9 and 9.5. Photographs were taken of each sample to demonstrate the visible changes in colour. A colour pen (for example, Dr Lange Colour Pcn), a pen-type colorimeter was used to detect marginal colour changes which are undetectable by the human eye. Colour pen measurements include, but are not limited, to three different readings: the L*, a* and b* values.

    • L* represents the lightness/luminosity of the colour
      • L*=0 is black
      • L*=100 is diffuse white
    • a* is the colour's position between red/magenta and green
      • A positive a* value indicates magenta
      • A negative a* value indicates green
    • b* is the colours position between yellow and blue
      • a positive b* value indicates yellow
      • a negative b* value indicates blue


Example 1: Post-Op Pad Dyed with GJM-514

A sample of the pad from an Opsite Post-Op dressing (Smith & Nephew) was covalently bound with the dye GJM-514 was exposed to buffered solutions at pH 5 pH 9.5. The panel of photographs in FIG. 3 demonstrates the colour change of GJM-514 over this pH range, going from yellow in colour (at pH5) to pink (at pH 9.5).


Table 2 illustrates the colour pen measurements (L*, a* and b*) of the colour of the GJM-514 dye over a pH range of pH 5-pH 9.5. An optimal dye for use as a pH indicator is one which demonstrates a linear change in a measurement of a specific parameter of colour (for example L*, a* or b*) over a broad pH range. Outside of the linear region, the dye is either unable to change colour in response to a change in pH or the change in colour is so minimal that it is undetectable.














TABLE 2







pH
L*
a*
b*





















5
63.3
−1.9
41.5



5.5
69.2
0.3
36.2



6
65.7
1.4
35.1



6.5
59.3
1.2
35.5



7
56.9
2
33.6



7.5
55.4
4.8
30.6



8
46.8
10.4
21.4



8.5
43.3
15.6
15.4



9
40.2
21.3
8.7



9.5
37.5
24.8
4.9











FIGS. 4A and 4B illustrate the L* measurements taken of the GJM-514 dye with the colour pen presented graphically. The L* results of FIG. 4A show that the L* value decreases from pH 5.5 to pH 9.5 as the luminosity of the dye decreases relative to the increasing pH. These results have also been plotted in FIG. 4B and demonstrate a linear region between pH 7.5 and 9.5. The trend line has a gradient of −8.18 and an R2 value of 0.9918.



FIGS. 4C and 4D illustrate the a* measurements taken of the GJM-514 dye with the colour pen presented graphically. FIG. 4C illustrates the a* measurements taken at various pH values between pH 5-pH 9.5. FIG. 4D illustrates the a* measurements at various pH values over the linear portion of the trend line, between pH 7.5 and 9. The trend line has a gradient of 10.94 and an R2 value of 0.9997.



FIGS. 4E and 4F illustrate a graphical representation of the b* measurements taken of the GJM-514 dye. FIG. 4E shows the b* measurements taken at various pH values between pH 5-pH 9.5. FIG. 4E illustrates the b* measurements at various pH values over the linear portion of a trend line. From FIG. 4E it can be seen that the values are fairly consistent and steady between pH 5.5 and pH 7, and after pH 7 they start to decrease. FIG. 4F shows that the results give a linear downward trend between pH 7.5 and pH 9, with a gradient of −14.34 and an R2 value of 0.991.


Taking into account the colour pen results and photographs of the samples, the most accurate working range for GJM514 is between pH 7.5 and pH 9. The linear trend line of the b* measurements has a steeper gradient (−14.34) than the a* measurements (10.94) and therefore b* would be used preferentially to give a more accurate indication of the pH of the dressing when using an optical reader rather than the human eye.


Example 2: Post-Op Pad Dyed with GJM-514:GJM-492 (1:1)

A sample of the pad from an Opsite Post-Op dressing (Smith & Nephew) was covalently bound with the dye GJM-514:GJM-492 at a 1:1 ratio was exposed to buffered solutions at pH 5-pH 9.5. The panel of photographs in FIG. 5 demonstrates the colour change over this pH range, going from yellow in colour (at pH 5) to orange in colour (at pH 9.5).


Table 3 illustrates the colour pen measurements (L*, a* and b*) of the colour of the GJM-514:GJM-492 dye combination over a pH range of pH 5-pH 9.5.














TABLE 3







pH
L*
a*
b*





















5
53.8
11.5
43.3



5.5
50.7
17.4
37.9



6
45.3
23.9
37.5



6.5
40.4
29.9
35.4



7
39.7
30.9
33.8



7.5
39.9
30.4
29.9



8
34.5
31.5
29.2



8.5
37.4
28
29.3



9
33.8
30.7
25



9.5
33.1
31.3
23.2











FIG. 6A illustrates the L* measurements taken with the colour pen presented graphically. The L* results presented in FIG. 6A show that the value for L* decreases over the range of pH 5.5 to pH 9.5 but does not follow a linear downward trend. The L* value is therefore not considered to be a reliable indicator of the colour change of this dye combination over the pH range tested.



FIGS. 6B and 6C illustrate the a* measurements taken with the colour pen presented graphically. FIG. 6B illustrates the a* measurements taken at various pH values between pH 5-pH 9.5. FIG. 6C illustrates the a* measurements at various pH values over the linear portion of a trend line. An upwardly linear trend (gradient=12.34, R2=0.9997) is identifiable between pH 5 and 6.5, demonstrating that there is a detectable change in colour along the red/magenta to green scale over this pH range.



FIG. 6D illustrates a graphical representation of the b* measurements taken with the colour pen. It can be seen that there is not a significant change in b* value, but there is a downwards trend.


Taking into account the colour pen results and photographs of the samples, the working range for this dye combination appears to be between pH 5 and pH 6.5. With a* giving a useable trend line for this region that could be used to estimate the pH from the material colour.


Example 3: Post-Op Pad Dyed with GJM-514:GJM-546 (1:1)

A sample of the pad from an Opsite Post-Op dressing (Smith & Nephew) was covalently bound with the dye GJM 514:546 at a 1:1 ratio was exposed to buffered solutions at pH 5-pH 9.5. The panel of photographs in FIG. 7 demonstrates the colour change over this pH range, going from orange in colour (at pH 5) to pink (at pH 9.5).


Table 4 illustrates the colour pen measurements (L*, a* and b*) of the colour of the GJM-514:GJM-546 dye combination over a pH range of pH 5-pH 9.5.














TABLE 4







pH
L*
a*
b*





















5
45.7
22.7
44.1



5.5
43.4
22.8
40.1



6
43.9
24.8
34.6



6.5
36.5
27
25



7
33.4
25.7
16



7.5
28.3
27.8
7.1



8
26.9
26.6
1.3



8.5
25.6
29.3
−0.7



9
24.5
28.8
−2.3



9.5
23.9
29.5
−3.8











FIGS. 8A and 8B illustrate a graphical representation of the L* measurements taken with the colour pen. FIG. 8A shows all data points whilst FIG. 8B is a re-plot of the data points in the linear region between pH 5 to pH 8. The trend line has a gradient of −6.3702 with an R2 value of 0.9982.



FIG. 8C illustrate the a* measurements taken with the colour pen presented graphically over the pH 5-pH 9.5 range. The results are too variable for the a* measurement to be considered of use in reliably measuring a colour change in the GJM 514:546 dye combination in response to changes in pH.



FIGS. 8D and 8E illustrate a graphical representation of the b* measurements taken with the colour pen. FIG. 8E shows the b* measurements taken at various pH values between pH 5-pH 9.5 and it can be seen that the results follow a downward trend from pH 5 to pH 8, but it appears to plateau after pH 8. FIG. 8E illustrates the b* measurements at various pH values over the linear portion of a trend line which has a gradient of −18.3 and an R2 of 0.9997. As the b* results gave a steeper gradient it is believed that monitoring the b* value would give a more accurate reading of the pH from the dressing colour. The working range for this dye combination appears to be pH 6 to pH 7.5.


Example 4: Post-Op Pad Dyed with GJM 514:534 (1:1)

A sample of the pad from an Opsite. Post-Op dressing (Smith & Nephew) was covalently bound with the dye GJM 514:534 at a 1:1 ratio was exposed to buffered solutions at pH 5-pH 9.5. The panel of photographs in FIG. 9 demonstrates the colour change over this pH range, going from yellow in colour (at pH 5) to red in colour (at pH 9.5).


Table 5 illustrates the colour pen measurements (L*, a* and b*) of the colour of the GJM-514:GJM-534 dye combination over a pH range of pH 5-pH 9.5














TABLE 5







pH
L*
a*
b*





















5
53.4
6.1
50.3



5.5
52.3
7.5
45.4



6
53.8
7.6
46.1



6.5
49.7
9.8
35.4



7
43.1
16.2
29.9



7.5
37.4
16.2
18.9



8
33.4
20.4
11.9



8.5
31.9
22.8
5.3



9
27.7
27.6
3.6



9.5
28.9
29.1
−0.5











FIGS. 10A and 10B illustrate a graphical representation of the L* measurements taken with the colour pen. FIG. 10A shows all data points whilst FIG. 10B shows only those data points in the linear region. A general downward trend from pH 6 to pH 9 is observed. The trend line has a gradient of −8.8286 and an R2 value of 0.9742.



FIGS. 10C and 10D illustrate the a* measurements taken with the colour pen presented graphically. FIG. 10C illustrates the a* measurements taken at various pH values between pH 5-pH 9.5. FIG. 10D illustrates the a* measurements at various pH values over the linear portion of a trend line. The results demonstrate an upwards trend between pH 6 to pH 9, with the trend line having a gradient of 6.6335 and an R2 value of 0.9924.



FIGS. 10E and 10F illustrate a graphical representation of the b* measurements taken with the colour pen. FIG. 10E shows the b* measurements taken at various pH values between pH 5-pH 9.5 and it can be seen that the results follow a downward trend until pH 9. The trend line illustrated in FIG. 10F has a gradient −16.314 and an R2 value of 0.9925 between pH 6 and pH9. From the colour pen measurements the working range of this dye combination is between pH 6 and pH 9, and the b* value could be used to accurately measure the pH from the material colour.


Example 5: Post-Op Pad Dyed with GJM 514:534 (1:0.509)

A sample of the pad from an Opsite Post-Op dressing (Smith & Nephew) was covalently bound with the dye GM 514:534 at a 1:0.509 ratio was exposed to buffered solutions at pH 5-pH 9.5. The panel of photographs in FIG. 11 demonstrates the colour change over this pH range, going from yellow in colour (at pH 5) to red in colour (at pH 9.5).


Table 6 illustrates the colour pen measurements (L*, a* and b*) of the colour of the GJM-514:GJM-534 dye combination over a pH range of pH 5-pH 9.5














TABLE 6







pH
L*
a*
b*





















5
55.4
4.9
43.1



5.5
57.6
2.9
42.6



6
56.8
3.4
42.7



6.5
51.2
5
40



7
49
8.8
34.7



7.5
39.8
11.4
23.5



8
39
17.6
15



8.5
36.5
22.4
10.1



9
34.2
24.3
5.8



9.5
32.3
25.3
0.3











FIG. 12A illustrates a graphical representation of the L* measurements taken with the colour pen. A general downward trend from pH 6 to pH 9.5 is observed.



FIGS. 12B and 12C illustrate the a* measurements taken with the colour pen presented graphically. FIG. 12B illustrates the a* measurements taken at various pH values between pH 5-pH 9.5. FIG. 12C illustrates the a* measurements at various pH values over the linear portion of a trend line. The results demonstrate a linear upwards trend between pH 6.5 to pH 8.5, with the trend line having a gradient of 8.72 and an R2 value of 0.9987.



FIGS. 12D and 12E illustrate a graphical representation of the b* measurements taken with the colour pen. FIG. 12D shows the b* measurements taken at various pH values between pH 5-pH 9.5 and it can be seen that the results follow a downward trend between pH 6 and pH 8.5. The trend line illustrated in FIG. 12E has a gradient 15.9 and an R2 value of 0.9833. Taking into account the colour pen results and the photographs of the samples, the working range of this dye combination is between pH 6 and pH 8.5, and the b* value could be used to accurately measure the pH from the material colour.


Examples 6 and 7

Further to the above general method for preparing covalently bonded dye, different materials were also used unto which to bind the dye.


A sample of a gauze (Kerlix Trademark of Covidiene) and polyvinyl alcohol foam (V.A.C. WhiteFoam, trade mark of KCl) were covalently bound with the dye GJM-546 and 492 in a ratio 1:3.92 as described throughout this disclosure.


These latter materials can be used as pH sensing fillers for Negative Pressure Wound Therapy (NPWT). They were evaluated by use of the following models and experiments.


Materials












Material

















Pork Meat (loin or shoulder 2 kg approx.



Intact skin and a surface area 20 × 20 cm



approx.)



pH sensitive VAC foam



pH sensitive gauze



Renasys drapes



Horse serum



Citric Acid



Sodium Bicarbonate











Equipment












Equipment

















Renasys EZ plus pump



Peristaltic pump



Renasys EZ canister



Epidural needle



Clingfilm



Tubing



Glass Dish



Scalpel



pH meter











Method


Use these solutions to adjust horse serum to pH 5 and pH 8, for use in the meat mode.

  • 1. Place a sheet of cling film in the bottom of a glass dish/tray and place a piece of pork with intact skin upwards on the cling film.
  • 2. Wrap the meat in the cling film and add more if necessary so that the meat is completely sealed.
  • 3. Using a scalpel create 2 wounds each approximately 50 mm in diameter and 25 mm deep in the tissue (and at least 2 cm apart), by removing the skin/fat/muscle, with a relatively flat bottom and minimal tissue flaps.
  • 4. Insert an epidural catheter needle through the side of the wound so that the tip appears at the outside edge of the meat. Use the needle to feed the peristaltic pump tubing through so that it lies at the base of the wound. (Repeat for the other wound).
  • 5. Using small pieces of Flexi-fix and/or adhesive putty (“white-tac”) secure and seal the openings where the fluid tubes exit the cling film.
  • 6. The following combinations are to be tested:
    • a. Dyed VAC foam
    • b. Dyed gauze
  • 7. Add foam to bridge onto intact healthy skin and link both bridges together to work from a single port. Seal over the wounds, fillers and bridging foam with drapes.
  • 8. Make a small hole in the drape where it lies over a foam bridge and attach a port using Flexi-fix strips.
  • 9. Connect the port to a RENASYS NPWT pump (set at −120 mmHg) and switch on.
  • 10. Turn on the peristaltic pump (set to deliver 40 μl/min) to deliver fluid to the wound bed of horse serum at pH 8
  • 11. Monitor the dressings until fluid starts to appear in the canister (make a note of the length of time)
  • 12. Change the fluid to horse serum at a pH of 5, and leave to flow for the amount of time determined in step 11). Then take a photograph of the dressings.
  • 13. Change the fluid to horse serum at a pH of 8, and leave to flow for the amount of time determined in step 11). Then take a photograph of the dressings.
  • 14. Change the fluid back to horse serum at a pH of 5, and leave to flow for the amount of time determined in step 11). Then take a photograph of the dressings.
  • 15. At the end of the experiment disconnect the tubing and seal the meat in cling film for disposal. Clean all surfaces that had contact with the meat with soap/water.


Determination of the ability of dyed VAC foam and gauze to detect changes in pH of wound fluid.


The pH sensitive gauze and VAC foam were washed after the first meat model experiment and then used in an additional wound model, with pH adjusted water. In addition the extra piece of pH sensitive dyed gauze was placed in a clear Perspex wound model and fluid pumped through.


All wound models were monitored by taking photographs, those carried out in meat could only be monitored from the top surface, but the clear Perspex model could be monitored from all sides.


Results and Discussion


The foam was orange in colour when it was loaded into the wound, but the gauze was more of a red colour. It is believed the gauze is red in colour due to the presence of PHMB on the gauze which would make it basic.


Meat Model 1


The experiment was started by pumping pH 5 horse serum into the wound filler for approximately 2.5 hours before fluid started to appear in the canister and the material started to change colour. After approximately 5.5 hours the pH 5 horse serum solution was changed to pH 8 horse serum and this was run overnight. In the morning the solution was then changed back to pH 5 horse serum and was pumped in for several hours (due to time restrictions the flow rate was increased to 80 μl/min after 3.5 hours).


The images of the pH sensitive dyed gauze changing over time can be seen in FIG. 13A to F; showing that the gauze had started to go orange after 5.5 hours of exposure to pH 5 horse serum and after a night of exposure to pH 8 serum the gauze had returned to a red colour. Then after several hours of exposure to pH 5 the gauze was starting to turn orange again at which time the experiment was ended. Upon removal of the gauze it could be seen that the bottom of the gauze was mostly orange and it could be seen that the colour and therefore the pH were changing through the gauze in a direction from the wound bed towards the drape, which can be explained by the fact that the wound tends to fill up like the filling of a bath and therefore the pH takes time to change from one pH to the other as the pumped fluid is slowly transported through the wound filler.


Images of the pH sensitive dyed VAC foam changing over time can be seen in FIG. 14 A to F They show that the foam had gone yellow when exposed to pH 5 horse serum (5.5 hours image), and that when exposed to pH 8 overnight the foam went red. As with the gauze the foam had started to turn yellow/orange after re-exposure to pH 5 serum for several hours before the experiment was ended, the yellow/orange colour can most clearly be seen near the bridging foam.


Meat Model 2


For the second meat model the basic aqueous solution was used first and was left pumping into the model overnight. The next morning the solution was then changed to an acidic aqueous solution and left pumping for several hours.


The images for the pH sensitive gauze can be seen in FIG. 15A to F and show that the gauze went red in colour in basic solution and within 5 hours of the fluid being switched to acidic aqueous solution the gauze had started to turn orange. It is believed that this colour change will originate at the base of the wound and work its way up to the surface as the pH in the wound changes, which as mentioned earlier would be similar to the way in which a bath fills up. It is clear the colour change on the surface starts near the area directly below the port, this can be explained as this is the destination (exit point) of the fluid and so the pH would stabilises around this area on the surface first.


The same trend is seen with the dyed VAC foam, as shown in FIG. 16A to F The foam turns red when in the presence of basic fluid and when the fluid is changed to acidic the foam starts to turn yellow in colour. Like the gauze the colour change seen on the surface is first noticeable around the port where the fluid is removed from the wound.


Clear Perspex Wound Model


The experiment was also carried out using the pH sensitive dyed gauze in a clear Perspex wound model to be able to visualise the colour change throughout the wound. The fluid was not pumped in from the bottom on this occasion but from the left hand side of the wound as seen on the images in FIG. 17A to H. The fluid inlet is on the same side as the port and halfway up the wound wall. It is believed that the area of this wound is smaller than those created in the meat, hence the colour change occurring faster as the pump speed is the same in both experiments. It can be seen that as the basic fluid is pumped into the wound the gauze turns red (at T=0 hours there was already some basic fluid in the wound hence part of the gauze already being red in colour). It can be seen from all the images in FIG. 17 A to H, both the top surface of the wound (top image) and the bottom (bottom image of each pair), that the colour change moves across the wound from left to right and that the bottom of the wound is slightly ahead of the upper surface of the wound. This colour change pattern is as expected, as fluid fills up from the bottom and so the pH changes at the bottom before the top. The Perspex model is not as realistic as the meat model as the fluid and content from the meat would mean that the pH could take longer to change due to possible buffering effects.


CONCLUSIONS AND RECOMMENDATIONS

Both the pH sensitive dyed VAC foam and gauze, changed colour as they were exposed to different pH solutions. The colours for indicating the different pH's were clearly visible, and the colour could be reversed by addition of the other pH solution to the wound.


It is to be understood that the foregoing description is merely illustrative and is not to be limited to the details given. While several embodiments have been provided in the present disclosure, it should be understood that the disclosed devices and method and their components, may be embodied in many other specific forms without departing from the scope of the disclosure.


Variations and modifications will occur to those of skill in the art after reviewing this disclosure. The disclosed features may be implemented, in any combination and sub-combinations (including multiple dependent combinations and sub-combinations), with one or more other features described herein. The various features described or illustrated above, including any components thereof may be combined or integrated in other systems. Moreover, certain features may be omitted or not implemented.


Examples of changes, substitutions, and alterations are ascertainable by one skilled in the art and could be made without departing from the scope of the information disclosed herein. All references cited herein are incorporated by reference in their entirety and made part of this application.

Claims
  • 1. An article of manufacture, comprising: a fluid-contacting surface, wherein the article of manufacture further comprises a gel positioned on the fluid-contacting surface, the gel configured to contact the fluid, the gel comprising a pH indicator comprising 2-[(4-(2-hydroxyethylsulfonyl)-phenyl)diazenyl]-4-methylphenol and 4-[4-(2-hydroxyethylsulphonyl)-phenylazo]-2,6-dimethoxy phenol in about a 2:1 ratio.
  • 2. The article of claim 1, wherein the gel is an adhesive.
  • 3. The article of claim 1, further comprising a conduit configured to direct fluid to the pH indicator.
  • 4. The article of claim 1, wherein the fluid contacting surface comprises a film.
  • 5. The article of claim 1, wherein the fluid contacting surface comprises an absorbent pad.
  • 6. The article of claim 1, wherein the fluid contacting surface comprises a mesh.
  • 7. The article of claim 1, wherein the article is configured to indicate food spoilage.
  • 8. The article of claim 7, wherein the article is configured to be positioned on a food package.
  • 9. The article of claim 1, wherein the article is configured to be placed in a wound.
  • 10. The article of claim 1, wherein the fluid-contacting surface is a coating, the coating configured to be placed on a packaging material.
  • 11. The article of claim 1, wherein the article is configured to monitor drug release.
  • 12. The article according to claim 1, wherein the colour change in the pH indicator is detectable at a 0.1 unit interval change in pH.
  • 13. The article according to claim 12, wherein the colour change in the pH indicator is detectable between about pH 5 and about pH 10.
  • 14. The article according to claim 13, wherein the colour change in the pH indicator is detectable between about pH 5.5 and about pH 9.5.
  • 15. The article according to claim 13, wherein the colour change in the pH indicator is detectable between about pH 6.5 and 9.5.
  • 16. The article according to claim 1, wherein the article comprises a cellulosic material.
  • 17. The article according to claim 1, wherein the article comprises a peripheral edge, the pH indicator positioned on the peripheral edge.
Priority Claims (1)
Number Date Country Kind
1317746.4 Oct 2013 GB national
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 14/650,547, filed Jun. 8, 2015, which is a 371 of International Application No. PCT/EP2014/071520, filed Oct. 8, 2014, which claims the benefit of United Kingdom Application No. 1317746.4, filed Oct. 8, 2013. The entire contents of the above applications are incorporated herein by reference.

US Referenced Citations (364)
Number Name Date Kind
2249867 Snelling Jul 1941 A
3675654 Baker et al. Jul 1972 A
3759261 Wang Sep 1973 A
3896802 Williams Jul 1975 A
3972328 Chen Aug 1976 A
4029598 Neisius et al. Jun 1977 A
4192311 Felfoldi Mar 1980 A
4705513 Sheldon et al. Nov 1987 A
4728499 Fehder Mar 1988 A
4813942 Alvarez Mar 1989 A
4885077 Karakelle et al. Dec 1989 A
4999306 Yafuso et al. Mar 1991 A
5056510 Gilman Oct 1991 A
5104660 Chvapil et al. Apr 1992 A
5181905 Flam Jan 1993 A
5238732 Krishnan Aug 1993 A
5277872 Bankert et al. Jan 1994 A
5536783 Olstein et al. Jul 1996 A
5549584 Gross Aug 1996 A
5571684 Lawrence et al. Nov 1996 A
5678448 Fullen et al. Oct 1997 A
5690610 Ito et al. Nov 1997 A
5690624 Sasaki et al. Nov 1997 A
5707499 Joshi et al. Jan 1998 A
5759570 Arnold Jun 1998 A
5766212 Jitoe et al. Jun 1998 A
5788687 Batich et al. Aug 1998 A
5852126 Barnard et al. Dec 1998 A
5853669 Wolfbeis Dec 1998 A
5897516 Kadash et al. Apr 1999 A
6071267 Zamierowski Jun 2000 A
6095992 Augustine Aug 2000 A
6120904 Hostettler et al. Sep 2000 A
6284942 Rabin Sep 2001 B1
6333093 Burrell et al. Dec 2001 B1
6381482 Jayaraman et al. Apr 2002 B1
6388043 Langer et al. May 2002 B1
6482491 Samuelsen et al. Nov 2002 B1
6517484 Wilk et al. Feb 2003 B1
6551252 Sackner et al. Apr 2003 B2
6626891 Ohmstede Sep 2003 B2
6685681 Lockwood et al. Feb 2004 B2
6688525 Nelson et al. Feb 2004 B1
6696240 Kloepfer et al. Feb 2004 B1
6731987 McAdams et al. May 2004 B1
6747185 Inoue et al. Jun 2004 B2
6752794 Lockwood et al. Jun 2004 B2
6772708 Klofta et al. Aug 2004 B2
6936037 Bubb et al. Aug 2005 B2
6951553 Bubb et al. Oct 2005 B2
6979324 Bybordi et al. Dec 2005 B2
7004915 Boynton et al. Feb 2006 B2
7070584 Johnson et al. Jul 2006 B2
7077832 Fleischmann Jul 2006 B2
7108683 Zamierowski Sep 2006 B2
7159532 Klofta et al. Jan 2007 B2
7201063 Taylor et al. Apr 2007 B2
7206623 Blank et al. Apr 2007 B2
7216651 Argenta et al. May 2007 B2
7316652 Dalgaard et al. Jan 2008 B2
7361184 Joshi Apr 2008 B2
7381859 Hunt et al. Jun 2008 B2
7429255 Thompson Sep 2008 B2
7520875 Bernabei Apr 2009 B2
7521292 Rogers et al. Apr 2009 B2
7569742 Haggstrom et al. Aug 2009 B2
7605298 Bechert et al. Oct 2009 B2
7615036 Joshi et al. Nov 2009 B2
7622629 Aail Nov 2009 B2
7625362 Boehringer et al. Dec 2009 B2
7687678 Jacobs Mar 2010 B2
7699823 Haggstrom et al. Apr 2010 B2
7708724 Weston May 2010 B2
7722582 Lina et al. May 2010 B2
7749531 Booher Jul 2010 B2
7759537 Bishop et al. Jul 2010 B2
7759539 Shaw et al. Jul 2010 B2
7775998 Riesinger Aug 2010 B2
7777092 Lykke et al. Aug 2010 B2
7779625 Joshi et al. Aug 2010 B2
7811269 Boynton et al. Oct 2010 B2
7838717 Haggstrom et al. Nov 2010 B2
7846141 Weston Dec 2010 B2
7873141 Imai et al. Jan 2011 B2
7877866 Greenberg et al. Feb 2011 B1
7904133 Gehman et al. Mar 2011 B2
7910791 Coffey Mar 2011 B2
7922703 Riesinger Apr 2011 B2
7945302 McAdams May 2011 B2
7959624 Riesinger Jun 2011 B2
7964766 Blott et al. Jun 2011 B2
7976519 Bubb et al. Jul 2011 B2
8019401 Smith et al. Sep 2011 B1
8032210 Finneran et al. Oct 2011 B2
8034037 Adams et al. Oct 2011 B2
8060174 Simpson et al. Nov 2011 B2
8062272 Weston Nov 2011 B2
8062331 Zamierowski Nov 2011 B2
8079247 Russell et al. Dec 2011 B2
8080702 Blott et al. Dec 2011 B2
8111165 Ortega et al. Feb 2012 B2
8116841 Bly et al. Feb 2012 B2
8118794 Weston et al. Feb 2012 B2
8152785 Vitaris Apr 2012 B2
8162907 Heagle Apr 2012 B2
8207392 Haggstrom et al. Jun 2012 B2
8238996 Burnes Aug 2012 B2
8241231 Bausewein et al. Aug 2012 B2
8241261 Randolph et al. Aug 2012 B2
8282611 Weston Oct 2012 B2
8303552 Weston Nov 2012 B2
8332053 Patterson et al. Dec 2012 B1
8333874 Currie et al. Dec 2012 B2
8366692 Weston Feb 2013 B2
8372049 Jaeb et al. Feb 2013 B2
8372050 Jaeb et al. Feb 2013 B2
8425478 Olson Apr 2013 B2
8425996 Gorski et al. Apr 2013 B2
8444612 Patel et al. May 2013 B2
8460255 Joshi et al. Jun 2013 B2
8480641 Jacobs Jul 2013 B2
8545466 Andresen et al. Oct 2013 B2
8568386 Malhi Oct 2013 B2
8628505 Weston Jan 2014 B2
8641691 Fink Feb 2014 B2
8663106 Stivoric et al. Mar 2014 B2
8663198 Buan et al. Mar 2014 B2
8682442 McAdams Mar 2014 B2
8715256 Greener May 2014 B2
8764732 Hartwell Jul 2014 B2
8783948 Panda et al. Jul 2014 B2
8788009 Greene et al. Jul 2014 B2
8795243 Weston Aug 2014 B2
8795257 Coulthard et al. Aug 2014 B2
8800386 Taylor Aug 2014 B2
8808274 Hartwell Aug 2014 B2
8818478 Scheffler et al. Aug 2014 B2
8829263 Haggstrom et al. Sep 2014 B2
8834451 Blott et al. Sep 2014 B2
8894590 Lamoise et al. Nov 2014 B2
8925392 Esposito et al. Jan 2015 B2
8927801 Klofta Jan 2015 B2
8934957 Dias et al. Jan 2015 B2
8934965 Rogers et al. Jan 2015 B2
8943897 Beauvais et al. Feb 2015 B2
8948839 Longinotti-Buitoni et al. Feb 2015 B1
8956336 Haggstrom et al. Feb 2015 B2
8974428 Shuler et al. Mar 2015 B2
8986940 McNulty et al. Mar 2015 B2
8997588 Taylor Apr 2015 B2
9000251 Murphy et al. Apr 2015 B2
9012714 Fleischmann Apr 2015 B2
9061095 Adie et al. Jun 2015 B2
9127665 Locke et al. Sep 2015 B2
9192531 Wu Nov 2015 B2
9199012 Vitaris et al. Dec 2015 B2
9204806 Stivoric et al. Dec 2015 B2
9220455 Sarrafzadeh et al. Dec 2015 B2
9220822 Hartwell et al. Dec 2015 B2
9226402 Hsu Dec 2015 B2
9282897 Ross, Jr. et al. Mar 2016 B2
9283118 Locke et al. Mar 2016 B2
9302033 Riesinger Apr 2016 B2
9311520 Burg et al. Apr 2016 B2
9314175 Jacofsky et al. Apr 2016 B2
9320473 Shuler Apr 2016 B2
9372123 Li et al. Jun 2016 B2
9375353 Vitaris et al. Jun 2016 B2
9375521 Hudspeth et al. Jun 2016 B2
9381283 Adams et al. Jul 2016 B2
9402988 Buchanan et al. Aug 2016 B2
9408573 Welch et al. Aug 2016 B2
9421309 Robinson et al. Aug 2016 B2
9427179 Mestrovic et al. Aug 2016 B2
9439599 Thompson et al. Sep 2016 B2
9445749 Erickson et al. Sep 2016 B2
9446178 Blott et al. Sep 2016 B2
9494474 Servati et al. Nov 2016 B2
9511215 Skiba Dec 2016 B2
9516758 Arora et al. Dec 2016 B2
9526439 Connelly et al. Dec 2016 B2
9554484 Rogers et al. Jan 2017 B2
9572507 Moore et al. Feb 2017 B2
9582072 Connor Feb 2017 B2
9585620 Paquet et al. Mar 2017 B2
9587991 Padiy Mar 2017 B2
9592007 Nuovo et al. Mar 2017 B2
9603560 Monty et al. Mar 2017 B2
9613911 Rogers et al. Apr 2017 B2
9629584 Macia Barber et al. Apr 2017 B2
9629986 Patel et al. Apr 2017 B2
9681993 Wu et al. Jun 2017 B2
9687195 Sims et al. Jun 2017 B2
9829471 Hammond Nov 2017 B2
10004643 Luckemeyer et al. Jun 2018 B2
20020062114 Murai et al. May 2002 A1
20020091347 Eakin Jul 2002 A1
20030033032 Lind et al. Feb 2003 A1
20030210810 Gee, Jr. et al. Nov 2003 A1
20040044299 Utsugi Mar 2004 A1
20040133090 Dostoinov et al. Jul 2004 A1
20040230132 Shehada Nov 2004 A1
20050105789 Isaacs et al. May 2005 A1
20050187146 Helmus et al. Aug 2005 A1
20050199055 Browne Sep 2005 A1
20050280531 Fadem et al. Dec 2005 A1
20060009744 Edrman et al. Jan 2006 A1
20060140999 Lendlein et al. Jun 2006 A1
20070048224 Howell et al. Mar 2007 A1
20070055209 Patel et al. Mar 2007 A1
20070129784 Lendlein et al. Jun 2007 A1
20070142762 Kaplan et al. Jun 2007 A1
20070173892 Fleischer et al. Jul 2007 A1
20070188759 Mehendale et al. Aug 2007 A1
20070191754 Aali Aug 2007 A1
20070225663 Watt et al. Sep 2007 A1
20070270774 Bergman et al. Nov 2007 A1
20070276207 Eagland et al. Nov 2007 A1
20080132821 Propp et al. Jun 2008 A1
20080167535 Stivoric et al. Jul 2008 A1
20080208151 Zacharias et al. Aug 2008 A1
20080306456 Riesinger Dec 2008 A1
20080319283 Cotton et al. Dec 2008 A1
20090062757 Long et al. Mar 2009 A1
20090125004 Shen et al. May 2009 A1
20090157024 Song Jun 2009 A1
20090190135 Clarizia et al. Jul 2009 A1
20090234306 Vitaris Sep 2009 A1
20090245601 Cohen et al. Oct 2009 A1
20090299251 Buan Dec 2009 A1
20090299306 Buan Dec 2009 A1
20100022990 Karpowicz et al. Jan 2010 A1
20100025831 Yamazaki et al. Feb 2010 A1
20100041968 Meschisen et al. Feb 2010 A1
20100112680 Brockwell et al. May 2010 A1
20100125258 Coulthard et al. May 2010 A1
20100166252 Ahmed et al. Jul 2010 A1
20100168695 Robles et al. Jul 2010 A1
20100168700 Schmidt et al. Jul 2010 A1
20100168727 Hancock et al. Jul 2010 A1
20100178203 Kane et al. Jul 2010 A1
20100268111 Drinan et al. Oct 2010 A1
20100305473 Yuzhakov Dec 2010 A1
20100318052 Ha et al. Dec 2010 A1
20110004088 Grossman Jan 2011 A1
20110004172 Eckstein et al. Jan 2011 A1
20110054283 Shuler Mar 2011 A1
20110092958 Jacobs Apr 2011 A1
20110118683 Weston May 2011 A1
20110218757 Callsen et al. Sep 2011 A1
20110224631 Simmons Sep 2011 A1
20110245682 Robinson et al. Oct 2011 A1
20110274593 Gorski et al. Nov 2011 A1
20110301441 Bandic et al. Dec 2011 A1
20120029306 Paquet et al. Feb 2012 A1
20120029307 Paquet et al. Feb 2012 A1
20120029410 Koenig et al. Feb 2012 A1
20120095380 Gergley et al. Apr 2012 A1
20120165717 Al Khaburi et al. Jun 2012 A1
20120190956 Connolly Jul 2012 A1
20120190989 Kaiser et al. Jul 2012 A1
20120201437 Ohnemus Aug 2012 A1
20120215190 Kawashima Aug 2012 A1
20120256750 Novak Oct 2012 A1
20120264163 Booher Oct 2012 A1
20120271265 Langdon Oct 2012 A1
20120277559 Kohl-Bareis et al. Nov 2012 A1
20120279101 Pretsch et al. Nov 2012 A1
20120316538 Heiser et al. Dec 2012 A1
20120323274 Lendlein et al. Dec 2012 A1
20130041235 Rogers et al. Feb 2013 A1
20130064772 Swiss et al. Mar 2013 A1
20130066285 Locke et al. Mar 2013 A1
20130066289 Song et al. Mar 2013 A1
20130087298 Phillips et al. Apr 2013 A1
20130090616 Neubauer Apr 2013 A1
20130121544 Sarrafzadeh et al. May 2013 A1
20130131621 Van Holten et al. May 2013 A1
20130138054 Fleischmann May 2013 A1
20130150814 Buan Jun 2013 A1
20130151223 Zamierowski et al. Jun 2013 A1
20130165878 Heagle Jun 2013 A1
20130200268 Rafferty et al. Aug 2013 A1
20130261409 Pathak et al. Oct 2013 A1
20130274629 Duesterhoft et al. Oct 2013 A1
20130274688 Weston Oct 2013 A1
20130303865 Rebec et al. Nov 2013 A1
20130317367 Shuler Nov 2013 A1
20140031663 Gallego et al. Jan 2014 A1
20140072190 Wu et al. Mar 2014 A1
20140098209 Neff Apr 2014 A1
20140107495 Marinelli et al. Apr 2014 A1
20140114268 Auguste et al. Apr 2014 A1
20140121487 Faybishenko et al. May 2014 A1
20140138441 Davalos et al. May 2014 A1
20140147611 Ackerman, Jr. et al. May 2014 A1
20140154789 Polwart et al. Jun 2014 A1
20140203797 Stivoric et al. Jul 2014 A1
20140206947 Isserow et al. Jul 2014 A1
20140228791 Hartwell Aug 2014 A1
20140232516 Stivoric et al. Aug 2014 A1
20140243709 Gibson et al. Aug 2014 A1
20140296749 Reid, Jr. et al. Oct 2014 A1
20140296808 Curran et al. Oct 2014 A1
20140298927 Allin et al. Oct 2014 A1
20140316359 Collinson et al. Oct 2014 A1
20140340857 Hsu et al. Nov 2014 A1
20140350882 Everett et al. Nov 2014 A1
20150025343 Gareau et al. Jan 2015 A1
20150032035 Banwell et al. Jan 2015 A1
20150055134 Papautsky et al. Feb 2015 A1
20150065965 Haggstrom et al. Mar 2015 A1
20150080685 Markle et al. Mar 2015 A1
20150138330 Krishnamoorthi May 2015 A1
20150141767 Rogers et al. May 2015 A1
20150182166 Evans et al. Jul 2015 A1
20150223716 Korkala et al. Aug 2015 A1
20150257644 Cao Sep 2015 A1
20150265743 Hanson et al. Sep 2015 A1
20150292968 Vogt et al. Oct 2015 A1
20150313476 Pisani et al. Nov 2015 A1
20150313533 Rapp et al. Nov 2015 A1
20150327777 Kostic et al. Nov 2015 A1
20150335254 Fastert et al. Nov 2015 A1
20150335288 Toth et al. Nov 2015 A1
20150351970 Dagger et al. Dec 2015 A1
20150359485 Berg et al. Dec 2015 A1
20160015962 Shokoueinejad Maragheh Jan 2016 A1
20160022223 Grundfest et al. Jan 2016 A1
20160029900 LaPlante et al. Feb 2016 A1
20160038064 Johnson Feb 2016 A1
20160038083 Ding et al. Feb 2016 A1
20160058380 Lee et al. Mar 2016 A1
20160066854 Mei et al. Mar 2016 A1
20160069743 McQuilkin et al. Mar 2016 A1
20160074234 Abichandi et al. Mar 2016 A1
20160081580 Bergelin et al. Mar 2016 A1
20160100790 Cantu et al. Apr 2016 A1
20160100987 Hartwell et al. Apr 2016 A1
20160101282 Bergelin et al. Apr 2016 A1
20160144084 Collinson et al. May 2016 A1
20160232807 Ghaffari et al. Aug 2016 A1
20160249810 Darty et al. Sep 2016 A1
20160262672 Hammond et al. Sep 2016 A1
20160262687 Vaidyanathan et al. Sep 2016 A1
20160287177 Huppert et al. Oct 2016 A1
20160298620 Cordoba et al. Oct 2016 A1
20160302729 Starr et al. Oct 2016 A1
20160354001 Buckley et al. Dec 2016 A1
20160367189 Aimone et al. Dec 2016 A1
20160367406 Barnett Dec 2016 A1
20170000407 Saxby et al. Jan 2017 A1
20170027498 Larson et al. Feb 2017 A1
20170079740 Hufnagel et al. Mar 2017 A1
20170086519 Vigano et al. Mar 2017 A1
20170086709 Khine et al. Mar 2017 A1
20170095208 Oberleitner et al. Apr 2017 A1
20170161893 Carnes et al. Jun 2017 A1
20170164865 Rafferty et al. Jun 2017 A1
20170164876 Hyde et al. Jun 2017 A1
20170172439 Zhu et al. Jun 2017 A1
20170183705 Hicks et al. Jun 2017 A1
20170234802 Hicks et al. Aug 2017 A1
20180008177 Shimuta et al. Jan 2018 A1
Foreign Referenced Citations (93)
Number Date Country
2003204827 May 2006 AU
101490556 Jul 2009 CN
201414880 Mar 2010 CN
103217503 Jul 2013 CN
105395184 Mar 2016 CN
34 43 101 May 1986 DE
20 2004 017 052 Jul 2005 DE
0 257 916 Mar 1988 EP
0 340 018 Nov 1989 EP
0 430 608 Jun 1991 EP
1 476 217 Mar 2008 EP
2 021 046 Mar 2012 EP
2 454 990 May 2012 EP
2 462 908 Jun 2012 EP
2 574 275 Apr 2013 EP
1 854 342 Jun 2014 EP
1 734 858 Jul 2014 EP
2 544 642 Jan 2015 EP
2 648 668 Jan 2015 EP
2 451 349 Apr 2016 EP
2 941 195 Dec 2016 EP
1 163 907 Oct 1958 FR
905040 Sep 1962 GB
1255395 Dec 1971 GB
S54-176283 Dec 1979 JP
S57-162304 Oct 1982 JP
H07-055788 Mar 1995 JP
2002-165757 Jun 2002 JP
2006-338521 Dec 2006 JP
2007-163350 Jun 2007 JP
2012-157438 Aug 2012 JP
20120059006 Jun 2012 KR
114854 Apr 2012 RU
WO 198300742 Mar 1983 WO
WO 1995029959 Nov 1995 WO
WO 199605873 Feb 1996 WO
WO 199812996 Apr 1998 WO
WO 199912581 Mar 1999 WO
WO 2002047737 Jun 2002 WO
WO 2005025447 Mar 2005 WO
WO 2005052572 Jun 2005 WO
WO 2005123170 Dec 2005 WO
WO 2006052839 May 2006 WO
WO 2006110502 Oct 2006 WO
WO 2006133430 Dec 2006 WO
WO 2007030379 Mar 2007 WO
WO 2008003920 Jan 2008 WO
WO 2008006150 Jan 2008 WO
WO 2008010604 Jan 2008 WO
WO 2008125995 Oct 2008 WO
WO 2009066105 May 2009 WO
WO 2009124100 Oct 2009 WO
WO 2009141777 Nov 2009 WO
WO 2009158128 Dec 2009 WO
WO 2010020919 Feb 2010 WO
WO 2010105053 Sep 2010 WO
WO 2010142959 Dec 2010 WO
WO 2011098575 Aug 2011 WO
WO 2011135285 Nov 2011 WO
WO 2011135286 Nov 2011 WO
WO 2011135287 Nov 2011 WO
WO 2011144888 Nov 2011 WO
WO 2012074509 Jun 2012 WO
WO 2012131237 Oct 2012 WO
WO 2012131386 Oct 2012 WO
WO 2012140378 Oct 2012 WO
WO 2012143665 Oct 2012 WO
WO 2013010907 Jan 2013 WO
WO 2013026999 Feb 2013 WO
WO 2013044226 Mar 2013 WO
WO 2013074509 May 2013 WO
WO 2013083800 Jun 2013 WO
WO 2013090810 Jun 2013 WO
WO 2013136181 Sep 2013 WO
WO 2013149078 Oct 2013 WO
WO 2014008348 Jan 2014 WO
WO 2014016759 Jan 2014 WO
WO 2014020440 Feb 2014 WO
WO 2014020443 Feb 2014 WO
WO 2014066913 May 2014 WO
WO 2014108476 Jul 2014 WO
WO 2014113253 Jul 2014 WO
WO 2014113770 Jul 2014 WO
WO 2015022334 Feb 2015 WO
WO 2015022340 Feb 2015 WO
WO 2015031216 Mar 2015 WO
WO 2015052225 Apr 2015 WO
WO 2015112095 Jul 2015 WO
WO 2015168720 Nov 2015 WO
WO 2016005288 Jan 2016 WO
WO 2016012219 Jan 2016 WO
WO 2016025438 Feb 2016 WO
WO 2016030752 Mar 2016 WO
Non-Patent Literature Citations (19)
Entry
International Search Report, re PCT Application No. PCT/EP2014/071510, dated Feb. 5, 2015.
International Preliminary Report for Patentability, re PCT Application No. PCT/EP2014/071510, dated Apr. 21, 2016.
International Search Report and Written Opinion, re PCT Application No. PCT/EP2014/071520, dated Feb. 5, 2015.
International Preliminary Report for Patentability, re PCT Application No. PCT/EP2014/071520, dated Apr. 21, 2016.
Kendall ULTEC Hydrocolloid Dressing (4″×4″), product ordering page, web page downloaded Jul. 13, 2014.
Loh, B.Y. et al., “Automated Mobile pH Reader on a Camera Phone”, IAENG International Journal of Computer Science, vol. 38(3), Aug. 2011, in 7 pages.
Advantec MFS, Inc., “Membrane Filters” (catalog), accessed Jan. 29, 2016 (publication date unknown, but believed to be copyright 2001-2011), in 17 pages. URL: http://www.advantecmfs.com/catalog/filt/membrane.pdf#page=11.
Protz, Kerstin: “Moderne Wundauflagen unterstutzen Heilungsprozess”, Wundversorgung: Indikation und Anwendung, Geriatrie Journal, Apr. 2005, pp. 3333-3339, with translation.
Raviglione, A. et al., “Real-Time Smart Textile-Based System to Monitor Pressure Offloading of Diabetic Foot Ulcers”, Journal of Diabetes Science and Technology, vol. 11, Sep. 2017, in 5 pages.
Smith & Nephew, “PICO Single Use Negative Pressure Wound Therapy System”, spiral booklet, Mar. 2011, in 7 pages.
Trupp, S., “Developemt of pH-sensitive indicator dyes for the preparation of micro-patterned optical sensor layers”, Sensors and Actuators B, vol. 150, Jul. 15, 2010, pp. 206-210, in 5 pages.
Aubakir, B. et al., “Vital Sign Monitoring Utilizing Eulerian Video Magnification and Thermography”, 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Aug. 16, 2016, pp. 3527-3530, in 4 pages.
Chen, C. et al., “A PNIPAM-based fluorescent nanothermometer with ratiometric readout”, Chemical Communications, vol. 47, No. 3, Nov. 26, 2010, in 3 pages.
Dargaville, T. et al., “Sensors and imaging for wound healing: A review,” Biosensors and Bioelectronics, vol. 41, Mar. 2013, pp. 30-42, in 13 pages.
Farooqui, M. et al., “Low Cost Inkjet Printed Smart Bandage for Wireless Monitoring of Chronic Wounds”, Scientific Reports, vol. 6, Jun. 29, 2016, in 14 pages.
McLeod, A. et al., “Motion Magnification for Endoscopic Surgery”, Progress in Biomedical Optics and Imaging, SPIE—International Society for Optical Engineering, Mar. 12, 2014, vol. 9036, in 8 pages.
Mohr, G. et al., “Design of acidochromic dyes for facile preparation of pH sensor layers”, Anal Bioanal Chem, vol. 392, pp. 1411-1418, in 8 pages.
Reddy, T. et al., “Synthesis and Characterization of Semi-Interpenetrating Polymer Networks Based on Polyurethane and N-isopropylacrylamide for Wound Dressing”, Journal of Biomedical Materials Research Part B: Applied Biomaterials, vol. 88B, No. 1, Sep. 8, 2008, in 9 pages.
Uchiyama, S. et al., “Fluorescent molecular thermometers based on polymers showing temperature-induced phase transitions and labeled with polarity-responsive benzofurazans”, Analytical Chemistry, Amercial Chemical Society, vol. 75, No. 21, Oct. 4, 2003, in 10 pages.
Related Publications (1)
Number Date Country
20180196021 A1 Jul 2018 US
Continuations (1)
Number Date Country
Parent 14650547 US
Child 15804748 US